MYRIAD GENETICS INC — Director's Dealing 2014

Mar 19, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2014-02-12

Reporting Person: MELDRUM PETER D (Director, President & C.E.O.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-02-12	Common Stock	G	29572.0	$0.0	Disposed	26084	Direct
2014-03-17	Common Stock	M	55000.0	$30.12	Acquired	81084	Direct
2014-03-17	Common Stock	S	55000.0	$35.151	Disposed	26084	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-03-17	Non-Qualified Stock Option (right to buy)	$30.12	M	55000.0	Disposed	2019-02-18	Common Stock (55000)	Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.